Emergent Biosolutions EBS Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's accrued expenses?
- Emergent Biosolutions (EBS) reported accrued expenses of $22M in Q1 2026.
- How has Emergent Biosolutions's accrued expenses changed year-over-year?
- Emergent Biosolutions's accrued expenses decreased by 10.9% year-over-year, from $24.7M to $22M.
- What is the long-term trend for Emergent Biosolutions's accrued expenses?
- Over 5 years (2020 to 2025), Emergent Biosolutions's accrued expenses has grown at a -13.2% compound annual growth rate (CAGR), from $84.6M to $41.8M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.